PFIZER INC
Government Contracts & Awards
ADVANCED TECHNOLOGY INTERNATIONAL: $19.6M Department of Health and Human Services Contract
$19,620,884ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
$303,999,997PFIZER INC: COVID-19 VACCINE PRODUCTION
$11,110,134,066Proprietary Tech & Patents
ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Weight Loss Drug. Why Are So Many Investors Still Ignoring the Stock?
There is more to this stock than meets the eye.
Pfizer Inc. (PFE) vs. Eli Lilly and Company (LLY): The Growth vs. Value Play in Pharma
Pfizer (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) offer unique divergent investment opportunities in the pharmaceutical industry. While one acts as a value and income play, the other stands out as a solid growth investment supported by rapid expansion in obesity and diabetes franchises. Pfizer Value Investment Play Pfizer (NYSE:PFE) has seen its valuation drop […]
Freehand Raises $75M to Scale AI Teams Managing Supply Chain Spend for Fortune 500 Companies
Freehand's AI Agents autonomously manage supply-chain spend for Meta, Unilever, Johnson & Johnson, Dunkin', Pfizer and Cardinal Health. Freehand's AI Agents autonomously manage supply-chain spend for Meta, Unilever, Johnson & Johnson, Dunkin', Pfizer and Cardinal Health among others. Freehand builds autonomous AI agents that run supply-chain spend for the world's largest enterprises — taking on procurement, supplier management, invoice and payment operations across complex categories such as log
Freehand Raises $75M to Scale AI Teams Managing Supply Chain Spend for Fortune 500 Companies
Battery Ventures is co-leading the round alongside NewRoad Capital Partners, with participation from PSP Growth, Nexus Venture Partners and othersFreehand's AI Agents autonomously manage supply-chain spend for Meta, Unilever, Johnson & Johnson, Dunkin', Pfizer and Cardinal Health SAN FRANCISCO, July 29, 2026 (GLOBE NEWSWIRE) -- Freehand, whose AI agents manage supply-chain spend for Fortune 500 enterprises, today announced $75 million in funding co-led by Battery Ventures and NewRoad Capital Par
Pfizer: Calling The Bottom - The Patent Cliff Is Real, But The Valuation Has Fallen Too Far
PFEâs non-COVID portfolio demonstrates resilience, with Padcev, Vyndamax, and new launches driving operational growth despite patent cliffs. Click to read.
Did FDA’s Priority Review of TALZENNA plus XTANDI in Earlier Prostate Cancer Just Shift Pfizer's (PFE) Investment Narrative?
Earlier this month, Pfizer announced that the FDA accepted for Priority Review a supplemental application for TALZENNA in combination with XTANDI to treat men with HRR gene‑altered metastatic castration‑sensitive prostate cancer, supported by positive Phase 3 TALAPRO‑3 results and existing approvals for later‑stage disease. This move could broaden Pfizer’s prostate cancer franchise into an earlier disease setting, potentially deepening its footprint in precision oncology and expanding the...
GOP Congressman Slams JD Vance's Silence Over CDC's $1.24 Billion Pfizer COVID Vaccine Contracts: 'Why Isn’t He Speaking Out'
Rep. Thomas Massie questions JD Vance's silence after the Trump CDC established a $1.24 Billion Pfizer COVID-19 vaccine contract.
Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.
Pfizer has a 6.8% yield at a time when the market's yield is roughly 1%: Is there something wrong?
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer
Income seekers shouldn't give up on the stock yet.
PFE's Talzenna sNDA Gets FDA Priority Tag in Wider Prostate Cancer Use
Pfizer's Talzenna plus Xtandi combo wins FDA priority review for HRR gene-mutated metastatic castration-sensitive prostate cancer.
Congressional Trades in $PFE
Insider Trades (Form 4)
BOURLA ALBERT
BOURLA ALBERT
BOURLA ALBERT
DAMICO JENNIFER B.
BOURLA ALBERT
Key People
DAMICO JENNIFER B
SVP & Controller
BOURLA ALBERT
Chairman & CEO
Political Giving
$414,000 given to 78 candidates across 232 disclosed contributions (FEC Schedule A).
Nicole Malliotakis
Darin McKay LaHood
Nanette Barragan
Adrian Smith
Katherine M. Clark
Bradley S. Schneider
Ann Wagner
Carol Devine Miller
Deborah Ross
Linda T. Sanchez
Scott H. Peters
Suzan K. DelBene
Lloyd K. Smucker
Richard W. Allen
Earl Leroy Carter
Guy Mr Reschenthaler
Terri A. Sewell
Gus M. Bilirakis
Kevin Hern
John Cornyn
+ 58 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro